[1] Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis. Semin Respir Crit Care Med, 2018, 39:271-285.
[2] GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis, 2018, 18:261-284.
[3] Yang Y, Li J, Ma Z, et al. Global stability of two models with incomplete treatment for tuberculosis. Chaos Solitons & Fractals, 2017, 43:79-85.
[4] Pym AS , Diacon AH , Tang SJ , et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J, 2015, 47:564-574.
[5] Kumawat K, Pathak SK, Spetz AL, et al. Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factor-α production and macrophage apoptosis. J Biol Chem, 2016, 291:665-666.
[6] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 肝脏, 2015,20:750-769.
[7] 中华医学会结核病学分会,《中华结核和呼吸杂志》编辑委员会.抗结核药所致药物性肝损伤诊断与处理专家建议.中华结核和呼吸杂志,2013,36:732-736.
[8] Lin PL, Flynn JL. CD8 T cells and Mycobacterium tuberculosis infection. Semin Immunopathol, 2015, 37:239-249.
[9] Kubler A, Larsson C, Luna B. Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis. J Infect Dis, 2015, 213:618-623.
[10] 孙秋兰,马艳.多模式数字化健康教育在肺结核患者中的应用.中国国境卫生检疫,2019,42:336-338.
[11] 顾瑾. 水飞蓟宾预防抗结核药物所致肝损伤的多中心随机开放临床研究. 中国防痨杂志, 2016, 38:23-31.
[12] 杨雪迎, 李艳, 李哲明, 等. 护肝药物预防抗结核药物所致肝损伤的作用. 实用医学杂志, 2015,31:2194-2196.
[13] 郑锋玲, 骆欢欢. 肠道菌群与慢性肝损伤关系的研究进展. 广东医学, 2015,36:2269-2271.
[14] 文露, 彭芳. 肝病患者粪便上清代谢组学研究及肠道菌群对代谢的影响. 医学综述, 2017, 23:1076-1079
[15] 厉永强. 美能片剂联合水飞蓟宾葡甲胺片治疗抗结核药物性肝损的疗效观察. 中外医学研究, 2015,13:17-19. |
